Company Overview and News

to your dashboard

Headline News

NANO Arm Profits for Bruker, MERLIN Buyout Holds Promise

2018-01-08 zacks
On January 5th, we issued an updated research report on Bruker Corporation (BRKR - Free Report) . The stock carries a Zacks Rank #2 (Buy). (30-0)

Abaxis Well Poised on Solid Prospects, Competition Rife

2017-12-27 zacks
On Dec 26, we issued an updated research report on Abaxis, Inc. (ABAX - Free Report) . The stock currently carries a Zacks Rank #3 (Hold). (34-0)

Cerner Gains Momentum in HCIT Space Amid Tough Competition

2017-12-27 zacks
On Dec 26, we issued an updated research report on Cerner Corporation (CERN - Free Report) . The stock carries a Zacks Rank #3 (Hold). (50-0)

IRadimed (IRMD) Hits 52-Week High: What's Driving the Stock?

2017-12-27 zacks
IRadimed Corporation (IRMD - Free Report) scaled a fresh 52-week high of $15.75 on Dec 26, closing nominally lower at $15.70. The company has rallied 32.5% over the last year, much higher than the S&P 500’s gain of 18.6%. (40-0)

Becton, Dickinson (BDX) a Step Closer to Bard Acquisition

2017-12-27 zacks
Shares of Becton, Dickinson and Company (BDX - Free Report) fell 0.3% to $217.02 on Dec 26 following the Federal Trade Commission’s (FTC) nod for the much talked about C. R. Bard (BCR - Free Report) acquisition. C.R. Bard was however up 0.6% and closed at $333.41. (58-0)

Zimmer Biomet Strong on Positive Data From PROGRESS II Study

2017-12-26 zacks
Zimmer Biomet Holdings, Inc. (ZBH - Free Report) recently announced positive results from PROGRESS II for treatment of knee osteoarthritis (OA). Data from the study (based on 46 patients with symptomatic knee OA pain from the four trial sites across Europe) demonstrated the safety and efficacy of the nSTRIDE Autologous Protein Solution (APS) Kit for the therapy. (76-0)

Here's Why You Should Invest in Masimo (MASI) Right Now

2017-12-26 zacks
Shares of Masimo Corporation (MASI - Free Report) have rallied 27.3% over a year, ahead of the S&P 500 index’s 18.6% gain and the broader industry’s 20.5% rise. The stock has a market cap of $4.46 billion. (70-0)

Haemonetics Banks on Hospital Business, Competition Rife

2017-12-26 zacks
On Dec 22, we issued an updated research report on Haemonetics Corporation (HAE - Free Report) . The stock currently carries a Zacks Rank #3 (Hold). (66-0)

Wired News – Bruker Announces 10-Year Partnership with Metropolitan Museum of Art to Advance Novel Analytical Technologies

2017-12-15 accesswire
LONDON, UK / ACCESSWIRE / December 15, 2017 / Active-Investors issued a free report on Bruker Corp. (NASDAQ: BRKR), which is readily accessible upon registration at as the Company's latest news hit the wire. On December 13, 2017, the Company announced that it has signed a 10-year partnership with the Metropolitan Museum of Art ("The Met") to further advance novel analytical technologies and methods in the field of cultural heritage science. (19-0)

The Zacks Analyst Blog Highlights: Bruker, Dana, Fair Isaac, Skechers and SodaStream

2017-11-29 zacks
Chicago, IL – November 29, 2017 – announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Bruker (BRKR - Free Report) , Dana Inc. (DAN - Free Report) , Fair Isaac Corp. (FICO - Free Report) , Skechers (SKX - Free Report) and SodaStream (SODA - Free Report) . (75-0)

5 Strong Buy Stocks Gaining Momentum

2017-11-28 zacks
My what a difference a few weeks makes. A few weeks ago, news of a North Korean missile test in the Sea of Japan would have sent the market tumbling. Today, it was little more than a buying opportunity as the market quickly shook off the intraday selling to surge higher into the close, pushing deeper into record territory. (17-0) highlights: Natus Medical, GoPro, Enviva Partners and Bruker

2017-11-15 zacks
Chicago, IL – November 15, 2017 - Stocks in this week’s article include: Natus Medical Inc (BABY - Free Report) , GoPro Inc (GPRO - Free Report) , Enviva Partners LP (EVA - Free Report) and Bruker Corporation (BRKR - Free Report) . (64-0)

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bruker Corporation (BRKR)

2017-11-13 accesswire
NEW YORK, NY / ACCESSWIRE / November 13, 2017 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bruker Corporation ("Bruker" or the "Company") (NASDAQ: BRKR). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: (10-0)

Bruker's NANO Grows Strong, MERLIN Buyout Holds Promise

2017-11-10 zacks
On Nov 08, we issued an updated research report on Bruker Corporation (BRKR - Free Report) . The stock carries a Zacks Rank #3 (Hold). (13-0)

Bruker (BRKR) a Buy on Strong Quant Score

2017-11-09 investorplace
Bruker Corp (NASDAQ:BRKR) is classified as a component of the 33 company Life Sciences Tools & Services GICS industry group, which is part of the 785 company GICS Health Care sector. BRKR's market value is $5.3 billion which falls in the upper half of its industry group. The ranking for BRKR by Portfolio Grader places it 9 among the 33 companies in this industry group, placing it in the top half; in the top quartile of the sector with a ranking of 98 among the 785 companies in the sector, and number 641 in the nearly 5,000 company Portfolio Grader universe. (10-0)

CUSIP: 116794108